References
- Akobeng AK. (2007). Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 96:644–7
- Alhosin M, Abusnina A, Achour M, et al. (2010). Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. Biochem Pharmacol 79:1251–60
- Arima Y, Hirota T, Bronner C, et al. (2004). Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes Cells 9:131–42
- Babbio F, Pistore C, Curti L, et al. (2012). The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression. Oncogene 31:4878–87
- Bray F, Ren JS, Masuyer E, Ferlay J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133–45
- Bronner C, Achour M, Arima Y, et al. (2007). The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?. Pharmacol Ther 115:419–34
- Cenitagoya GF, Bergh CK, Klinger-Roitman J. (1998). A prospective study of gastric cancer. ‘Real’ 5-year survival rates and mortality rates in a country with high incidence. Dig Surg 15:317–22
- Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al. (2005). Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology 129:1454–63
- Daskalos A, Oleksiewicz U, Filia A, et al. (2011). UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer. Cancer 117:1027–37
- Ferlay J, Soerjomataram I, Ervik M, et al. (2013). GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer. [Online] Available at: http://globocan.iarc.fr. [last accessed 15 Jul 2014]
- Geng Y, Gao Y, Ju H, Yan F. (2013). Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients. Cancer Sci 104:194–9
- Hohenberger P, Gretschel S. (2003). Gastric cancer. Lancet 362:305–15
- Jeanblanc M, Mousli M, Hopfner R, et al. (2005). The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1/S transition during the cell cycle. Oncogene 24:7337–45
- Jenkins Y, Markovtsov V, Lang W, et al. (2005). Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Mol Biol Cell 16:5621–9
- Kim JK, Esteve PO, Jacobsen SE, Pradhan S. (2009). UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res 37:493–505
- Li J, Jin H, Wang X. (2014). Epigenetic biomarkers: potential applications in gastrointestinal cancers. ISRN Gastroenterol 2014:464015
- Mattar R, Alves De Andrade CR, Difavero GM, Gama-Rodrigues JJ, Laudanna AA. (2002). Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med Sao Paulo 57:89–92
- Sabatino L, Fucci A, Pancione M, et al. (2012). UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression. Oncogene 31:5061–72
- Unoki M, Daigo Y, Koinuma J, et al. (2010). UHRF1 is a novel diagnostic marker of lung cancer. Br J Cancer 103:217–22
- Unoki M, Kelly JD, Neal DE, et al. (2009). UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer 101:98–105
- Unoki M, Nishidate T, Nakamura Y. (2004). ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain. Oncogene 23:7601–10
- Zhou L, Zhao X, Han Y, et al. (2013). Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis. FASEB J 27:4929–39